Teva suffers legal setback in its bid to affirm Corcept patents – Seeking Alpha

Teva Pharmaceutical (TEVA) has lost its attempt to invalidate a patent for Cushing’s syndrome drug Korlym, marketed by Corcept Therapeutics (CORT) …